Westport Innovations Rallies on Acquisition Chatter and 3 Stock Analyses Making Rounds
February 19, 2013
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): Current Price: $57.18
William Blair has increased the company’s price target due to increased confidence in BMN-701 after the Lysosomal Disease Network WORLD Symposium. The firm still names BioMarin as a top pick for 2013 and reiterates its Outperform rating on stock.
These stocks are hitting our Profit Targets. Click here now to discover winning stocks!
Premium Newsletters
Gold & Silver
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
Learn More
Commodities Premium
There's always a bull market in some sector! Find the best opportunities in commodities.
Learn more
ETF Investing
At last, a trading system that buys the right ETFs at the right time, time after time!
Learn more
Wall St. Cheat Sheet has been featured in these fine media outlets:
